Multi-criteria optimization achieves superior normal tissue sparing in intensity-modulated radiation therapy for oropharyngeal cancer patients.

OBJECTIVES To evaluate the benefit of intensity-modulated radiation therapy (IMRT) with multi-criteria optimization (MCO) in patients with oropharyngeal cancer (OPC) and compare the dose difference between the MCO plans navigated by physicians and dosimetrists. MATERIALS AND METHODS The conventional IMRT plans (nonMCO) and MCO IMRT plans navigated by physicians and dosimetrists (MCOp and MCOd) were created for 30patients with OPC. All the plans were reviewed, and the planning time and dose-volume parameters were compared. RESULTS The difference of D95 among three kinds of plans was not significant (p > 0.05). The maximum dose and D2 of spinal cord, brain stem, the mean dose of bilateral parotids, cochlea, oral cavity and glottic larynx were lower in MCO plans than those in nonMCO plans (p < 0.017). Furthermore, MCOp showed better bilateral parotids, oral cavity and glottic larynx sparing compared to MCOd (p < 0.017), in which the magnitude was related to the overlapping volume of the corresponding organ at risk (OAR) and targets. The active planning time was reduced by a median of 94.3 min (MCOd vs. nonMCO) or 91.6 min (MCOp vs. nonMCO). CONCLUSION MCO IMRT plans significantly reduced the dose of OARs and the active planning time, without compromising the target coverage in OPC patients; navigations by physicians could be beneficial to the dose sparing of the OARs with high complication rate and those overlapping with targets; the constraints could be the predominant factor affecting the results of optimization in the MCO IMRT planning.

[1]  J. Deasy,et al.  A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. , 2001, International journal of radiation oncology, biology, physics.

[2]  Sandra Nuyts,et al.  Radiation‐induced xerostomia in patients with head and neck cancer , 2006, Cancer.

[3]  V. Wu,et al.  A comparison between anisotropic analytical and multigrid superposition dose calculation algorithms in radiotherapy treatment planning. , 2013, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[4]  David Craft,et al.  Multi-criteria optimization achieves superior normal tissue sparing in a planning study of intensity-modulated radiation therapy for RTOG 1308-eligible non-small cell lung cancer patients. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  Fernando Alonso,et al.  A new concept for interactive radiotherapy planning with multicriteria optimization: first clinical evaluation. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  Donna C. Tippett,et al.  Swallowing outcomes in patients with oropharyngeal cancer undergoing organ‐ preservation treatment , 2014, Head & neck.

[7]  Mika Kapanen,et al.  Quantification of dose differences between two versions of Acuros XB algorithm compared to Monte Carlo simulations — the effect on clinical patient treatment planning , 2015, Journal of applied clinical medical physics.

[8]  L. van der Molen,et al.  Dysphagia and trismus after concomitant chemo-Intensity-Modulated Radiation Therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  Jayashree Kalpathy-Cramer,et al.  Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: Dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  Marta Paiusco,et al.  IMRT treatment planning:- a comparative inter-system and inter-centre planning exercise of the ESTRO QUASIMODO group. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  F. Feng,et al.  Predictors of Dysgeusia in Patients With Oropharyngeal Cancer Treated With Chemotherapy and Intensity Modulated Radiation Therapy. , 2016, International journal of radiation oncology, biology, physics.

[12]  K. Griffith,et al.  Patient-reported voice and speech outcomes after whole-neck intensity modulated radiation therapy and chemotherapy for oropharyngeal cancer: prospective longitudinal study. , 2014, International journal of radiation oncology, biology, physics.

[13]  J. Deasy,et al.  The role of parotid gland irradiation in the development of severe hyposalivation (xerostomia) after intensity-modulated radiation therapy for head and neck cancer: Temporal patterns, risk factors, and testing the QUANTEC guidelines. , 2017, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[14]  Joseph O Deasy,et al.  Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy. , 2005, International journal of radiation oncology, biology, physics.

[15]  David Craft,et al.  Maximizing dosimetric benefits of IMRT in the treatment of localized prostate cancer through multicriteria optimization planning. , 2013, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[16]  K. Ang,et al.  Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.

[17]  Jiazhou Wang,et al.  Investigation of plan quality between RapidArc and IMRT for gastric cancer based on a novel beam angle and multicriteria optimization technique. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  P. Levendag,et al.  The impact of treatment modality and radiation technique on outcomes and toxicity of patients with locally advanced oropharyngeal cancer , 2013, The Laryngoscope.

[19]  J. Sciubba,et al.  Oral complications of radiotherapy. , 2006, The Lancet. Oncology.

[20]  Kristoffer Petersson,et al.  Discrepancies between selected Pareto optimal plans and final deliverable plans in radiotherapy multi-criteria optimization. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  A. Garden,et al.  A multi‐institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity‐modulated radiotherapy , 2015, Cancer.

[22]  Avraham Eisbruch,et al.  Intensity-modulated radiation therapy for head and neck carcinoma. , 2007, The oncologist.

[23]  Emma Hall,et al.  Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial , 2011, The Lancet. Oncology.

[24]  B. Murphy,et al.  Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement. , 2016, Critical reviews in oncology/hematology.

[25]  Ping Xia,et al.  Can all centers plan intensity-modulated radiotherapy (IMRT) effectively? An external audit of dosimetric comparisons between three-dimensional conformal radiotherapy and IMRT for adjuvant chemoradiation for gastric cancer. , 2008, International journal of radiation oncology, biology, physics.

[26]  J. Giralt,et al.  Management of squamous cell carcinoma of the head and neck: updated European treatment recommendations , 2010, Expert review of anticancer therapy.

[27]  P. Levendag,et al.  Patients with head and neck cancer cured by radiation therapy: A survey of the dry mouth syndrome in long‐term survivors , 2002, Head & neck.

[28]  Christian Richter,et al.  Deliverable navigation for multicriteria step and shoot IMRT treatment planning , 2012, Physics in medicine and biology.

[29]  S. Loewen,et al.  Prospective swallowing outcomes after IMRT for oropharyngeal cancer: Dosimetric correlations in a population-based cohort. , 2016, Oral oncology.

[30]  David Craft,et al.  An approach for practical multiobjective IMRT treatment planning. , 2007, International journal of radiation oncology, biology, physics.

[31]  Philippe Després,et al.  Simultaneous integrated boost using intensity-modulated radiotherapy compared with conventional radiotherapy in patients treated with concurrent carboplatin and 5-fluorouracil for locally advanced oropharyngeal carcinoma. , 2012, International journal of radiation oncology, biology, physics.

[32]  Heikki Joensuu,et al.  Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[33]  A. Garden,et al.  Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes , 2014, Radiation oncology.

[34]  Ryan S. Lee,et al.  The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience. , 2017, Oral oncology.

[35]  G. Calais,et al.  Intensity-modulated radiotherapy in head and neck cancer: results of the prospective study GORTEC 2004-03. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[36]  R. Fisher,et al.  Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  Rasmus Bokrantz,et al.  Advantages and limitations of navigation-based multicriteria optimization (MCO) for localized prostate cancer IMRT planning. , 2014, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[38]  S. Franceschi,et al.  Oropharyngeal cancer prognosis by tumour HPV status in France: The multicentric Papillophar study. , 2017, Oral oncology.

[39]  Suzanne L Wolden,et al.  Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience. , 2012, International journal of radiation oncology, biology, physics.

[40]  J. Shah,et al.  Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes. , 2012, International journal of radiation oncology, biology, physics.

[41]  Fredrik Carlsson,et al.  Multicriteria optimization in intensity-modulated radiation therapy treatment planning for locally advanced cancer of the pancreatic head. , 2008, International journal of radiation oncology, biology, physics.